Foundation Medicine Announces Release of Molecular Information from FoundationCORE™ to the National Cancer Institute in Support of the National Cancer Moonshot and Precision Medicine Initiatives
Data will be Released to the NCI's Genomic Data Commons Portal to Advance Precision Medicine and Drive Improvements in Cancer Care
"This major infusion of data in the GDC will greatly enhance our ability to use this tool to explore genetic abnormalities in cancer," said
Run by the NCI, a part of the
"We're honored to participate in this important global effort to transform patient care and to be the first commercial entity to contribute data to the NCI's GDC, which we believe underscores the quality, integrity and richness of the genomics information contained in FoundationCORE," said
This collaboration with the NCI marks the second public release of information from FoundationCORE this year. In February,
About
Cautionary Note Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding Foundation Medicine's anticipated release of genomic data and the ability of genomic data from FoundationCORE to accelerate cancer research and drug development. All such forward-looking statements are based on management's current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include the risks that the release of genomic data by Foundation Medicine may not occur in the manner anticipated, may be delayed or may not occur at all; the data may not be as robust as anticipated; the release of this data or the use of the GDC generally does not generate or accelerate research and development activities; and the risks described under the caption "Risk Factors" in Foundation Medicine's Annual Report on Form 10-K for the year ended December 31, 2015, which is on file with the Securities and Exchange Commission, as well as other risks detailed in subsequent filings with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and Foundation Medicine undertakes no duty to update this information unless required by law.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160629005380/en/
Media Contact:
973-271-6085
dan@purecommunicationsinc.com
or
Investor Contact:
ir@foundationmedicine.com
Source:
News Provided by Acquire Media